Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Schrump

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implicationsDavid S Schrump
Biochimica Et Biophysica Acta|April 18, 2012
Targeting epigenetic mediators of gene expression in thoracic malignanciesDavid S Schrump
The Journal of Surgical Research|March 12, 2004
Genomic surgery for lung cancerDavid S Schrump
Seminars in Thoracic and Cardiovascular Surgery|June 16, 2015
Precision Therapy for Lung Cancer: Tyrosine Kinase Inhibitors and BeyondArun Rajan, David S Schrump
Thoracic Surgery Clinics|January 24, 2007
Lung cancer staging in the genomics eraDao M Nguyen, David S Schrump
Journal of Surgical Oncology|November 22, 2005
Novel molecular targeted therapy for esophageal cancerDavid S Schrump, Dao M Nguyen
Thoracic Surgery Clinics|December 3, 2014
Extended resections of non-small cell lung cancers invading the aorta, pulmonary artery, left atrium, or esophagus: can they be justified?Emily S Reardon, David S Schrump
Seminars in Oncology|October 8, 2005
Targeting the epigenome for the treatment and prevention of lung cancerDavid S Schrump, Dao M Nguyen
Seminars in Thoracic and Cardiovascular Surgery|September 16, 2004
Growth factor receptors as targets for lung cancer therapyDao M Nguyen, David S Schrump
Thoracic Surgery Clinics|January 24, 2007
Targeting the epigenome for the treatment of thoracic malignanciesDavid S Schrump, Dao M Nguyen
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implicationsDavid S Schrump
Biochimica Et Biophysica Acta|April 18, 2012
Targeting epigenetic mediators of gene expression in thoracic malignanciesDavid S Schrump
The Journal of Surgical Research|March 12, 2004
Genomic surgery for lung cancerDavid S Schrump
Seminars in Thoracic and Cardiovascular Surgery|June 16, 2015
Precision Therapy for Lung Cancer: Tyrosine Kinase Inhibitors and BeyondArun Rajan, David S Schrump
Thoracic Surgery Clinics|January 24, 2007
Lung cancer staging in the genomics eraDao M Nguyen, David S Schrump
Journal of Surgical Oncology|November 22, 2005
Novel molecular targeted therapy for esophageal cancerDavid S Schrump, Dao M Nguyen
Thoracic Surgery Clinics|December 3, 2014
Extended resections of non-small cell lung cancers invading the aorta, pulmonary artery, left atrium, or esophagus: can they be justified?Emily S Reardon, David S Schrump
Seminars in Oncology|October 8, 2005
Targeting the epigenome for the treatment and prevention of lung cancerDavid S Schrump, Dao M Nguyen
Seminars in Thoracic and Cardiovascular Surgery|September 16, 2004
Growth factor receptors as targets for lung cancer therapyDao M Nguyen, David S Schrump
Thoracic Surgery Clinics|January 24, 2007
Targeting the epigenome for the treatment of thoracic malignanciesDavid S Schrump, Dao M Nguyen
Pageof 16